<--- Back to Details
First PageDocument Content
Protein kinase inhibitors / Piperidines / Anaplastic lymphoma kinase / Lymphoma / Lung cancer / ALK inhibitor / Anaplastic large-cell lymphoma / Crizotinib / Non-small-cell lung carcinoma / ALK / Ceritinib / Carlo Gambacorti-Passerini
Date: 2016-04-15 08:51:39
Protein kinase inhibitors
Piperidines
Anaplastic lymphoma kinase
Lymphoma
Lung cancer
ALK inhibitor
Anaplastic large-cell lymphoma
Crizotinib
Non-small-cell lung carcinoma
ALK
Ceritinib
Carlo Gambacorti-Passerini

Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

Add to Reading List

Source URL: alkatras.erialcl.net

Download Document from Source Website

File Size: 1,08 MB

Share Document on Facebook

Similar Documents

Journal of Infection and Public Health, S31—S34  EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

DocID: 1vjEy - View Document

RESEARCH  Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

DocID: 1vfqs - View Document

Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth.

Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth.

DocID: 1v3MR - View Document

Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital

Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital

DocID: 1v06s - View Document

Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath

Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath

DocID: 1uZ8r - View Document